Transforming growth factor-β1 inhibits human arterial smooth-muscle cell proliferation in a growth-rate-Dependent manner

Brian G. Halloran, Greg D. Prorok, Byung J. So, Bernard Timothy Baxter

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background: Proliferation of arterial smoothmuscle cells is central in the development of both atherosclerosis and intimal hyperplasia. The cytokine transforming growth factor-beta 1 (TGF-β1) is known to have variable effects on smooth-muscle cell proliferation. Using human arterial smooth-muscle cells, we sought (1) to define the serum concentrations required to maintain cellular proliferation; and (2) to define the effects of TGF-β1 on smooth-muscle cell proliferation. Methods: Smooth-muscle cell cultures were established from the normal aorta of transplant donors. Cells were grown to subconfluent and confluent densities, then incubated in either serum-free media, or 1% or 10% fetal bovine serum (FBS) enhanced media. Cellular proliferation was assayed by cell counting at 24, 48, and 96 hours to establish growth rate. Identical experiments with the addition of recombinant human TGF-β1 (5 ng/mL) were also performed. Studies were done in triplicate for each group, and results expressed as the mean ± SE. Groups were compared by analysis of variance. Results: In subconfluent cultures, only smoothmuscle cells in 10% FBS proliferated, whereas growth arrest occurred in serum-free media and 1% FBS. In confluent cultures, cells in all media conditions proliferated. TGF-β1 had an inhibitory effect in actively proliferating cultures. There was a positive correlation between the inhibitory effects of TGF-β1 and smooth-muscle cell growth rate (r = .65; P = 0.005). Conclusions: When confluent, human arterial smooth-muscle cells continue to proliferate after serum deprivation, suggesting that these cells are capable of conditioning their own medium. TGF-β1 inhibits smooth-muscle cell proliferation in a growth-rate-dependent manner. These data suggest that TGF-B1 may have a growth-regulatory role in vascular disease by counteracting states of arterial smooth-muscle cell proliferation.

Original languageEnglish (US)
Pages (from-to)193-197
Number of pages5
JournalThe American Journal of Surgery
Volume170
Issue number2
DOIs
StatePublished - Aug 1995

Fingerprint

Transforming Growth Factors
Smooth Muscle Myocytes
Cell Proliferation
Transforming Growth Factor beta
Growth
Serum
Serum-Free Culture Media
Cell Culture Techniques
Tunica Intima
Vascular Diseases
Hyperplasia
Aorta
Atherosclerosis
Analysis of Variance
Tissue Donors
Cytokines

ASJC Scopus subject areas

  • Surgery

Cite this

Transforming growth factor-β1 inhibits human arterial smooth-muscle cell proliferation in a growth-rate-Dependent manner. / Halloran, Brian G.; Prorok, Greg D.; So, Byung J.; Baxter, Bernard Timothy.

In: The American Journal of Surgery, Vol. 170, No. 2, 08.1995, p. 193-197.

Research output: Contribution to journalArticle

@article{fdfd771dac924b558df4b403e3b136cb,
title = "Transforming growth factor-β1 inhibits human arterial smooth-muscle cell proliferation in a growth-rate-Dependent manner",
abstract = "Background: Proliferation of arterial smoothmuscle cells is central in the development of both atherosclerosis and intimal hyperplasia. The cytokine transforming growth factor-beta 1 (TGF-β1) is known to have variable effects on smooth-muscle cell proliferation. Using human arterial smooth-muscle cells, we sought (1) to define the serum concentrations required to maintain cellular proliferation; and (2) to define the effects of TGF-β1 on smooth-muscle cell proliferation. Methods: Smooth-muscle cell cultures were established from the normal aorta of transplant donors. Cells were grown to subconfluent and confluent densities, then incubated in either serum-free media, or 1{\%} or 10{\%} fetal bovine serum (FBS) enhanced media. Cellular proliferation was assayed by cell counting at 24, 48, and 96 hours to establish growth rate. Identical experiments with the addition of recombinant human TGF-β1 (5 ng/mL) were also performed. Studies were done in triplicate for each group, and results expressed as the mean ± SE. Groups were compared by analysis of variance. Results: In subconfluent cultures, only smoothmuscle cells in 10{\%} FBS proliferated, whereas growth arrest occurred in serum-free media and 1{\%} FBS. In confluent cultures, cells in all media conditions proliferated. TGF-β1 had an inhibitory effect in actively proliferating cultures. There was a positive correlation between the inhibitory effects of TGF-β1 and smooth-muscle cell growth rate (r = .65; P = 0.005). Conclusions: When confluent, human arterial smooth-muscle cells continue to proliferate after serum deprivation, suggesting that these cells are capable of conditioning their own medium. TGF-β1 inhibits smooth-muscle cell proliferation in a growth-rate-dependent manner. These data suggest that TGF-B1 may have a growth-regulatory role in vascular disease by counteracting states of arterial smooth-muscle cell proliferation.",
author = "Halloran, {Brian G.} and Prorok, {Greg D.} and So, {Byung J.} and Baxter, {Bernard Timothy}",
year = "1995",
month = "8",
doi = "10.1016/S0002-9610(99)80284-0",
language = "English (US)",
volume = "170",
pages = "193--197",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Transforming growth factor-β1 inhibits human arterial smooth-muscle cell proliferation in a growth-rate-Dependent manner

AU - Halloran, Brian G.

AU - Prorok, Greg D.

AU - So, Byung J.

AU - Baxter, Bernard Timothy

PY - 1995/8

Y1 - 1995/8

N2 - Background: Proliferation of arterial smoothmuscle cells is central in the development of both atherosclerosis and intimal hyperplasia. The cytokine transforming growth factor-beta 1 (TGF-β1) is known to have variable effects on smooth-muscle cell proliferation. Using human arterial smooth-muscle cells, we sought (1) to define the serum concentrations required to maintain cellular proliferation; and (2) to define the effects of TGF-β1 on smooth-muscle cell proliferation. Methods: Smooth-muscle cell cultures were established from the normal aorta of transplant donors. Cells were grown to subconfluent and confluent densities, then incubated in either serum-free media, or 1% or 10% fetal bovine serum (FBS) enhanced media. Cellular proliferation was assayed by cell counting at 24, 48, and 96 hours to establish growth rate. Identical experiments with the addition of recombinant human TGF-β1 (5 ng/mL) were also performed. Studies were done in triplicate for each group, and results expressed as the mean ± SE. Groups were compared by analysis of variance. Results: In subconfluent cultures, only smoothmuscle cells in 10% FBS proliferated, whereas growth arrest occurred in serum-free media and 1% FBS. In confluent cultures, cells in all media conditions proliferated. TGF-β1 had an inhibitory effect in actively proliferating cultures. There was a positive correlation between the inhibitory effects of TGF-β1 and smooth-muscle cell growth rate (r = .65; P = 0.005). Conclusions: When confluent, human arterial smooth-muscle cells continue to proliferate after serum deprivation, suggesting that these cells are capable of conditioning their own medium. TGF-β1 inhibits smooth-muscle cell proliferation in a growth-rate-dependent manner. These data suggest that TGF-B1 may have a growth-regulatory role in vascular disease by counteracting states of arterial smooth-muscle cell proliferation.

AB - Background: Proliferation of arterial smoothmuscle cells is central in the development of both atherosclerosis and intimal hyperplasia. The cytokine transforming growth factor-beta 1 (TGF-β1) is known to have variable effects on smooth-muscle cell proliferation. Using human arterial smooth-muscle cells, we sought (1) to define the serum concentrations required to maintain cellular proliferation; and (2) to define the effects of TGF-β1 on smooth-muscle cell proliferation. Methods: Smooth-muscle cell cultures were established from the normal aorta of transplant donors. Cells were grown to subconfluent and confluent densities, then incubated in either serum-free media, or 1% or 10% fetal bovine serum (FBS) enhanced media. Cellular proliferation was assayed by cell counting at 24, 48, and 96 hours to establish growth rate. Identical experiments with the addition of recombinant human TGF-β1 (5 ng/mL) were also performed. Studies were done in triplicate for each group, and results expressed as the mean ± SE. Groups were compared by analysis of variance. Results: In subconfluent cultures, only smoothmuscle cells in 10% FBS proliferated, whereas growth arrest occurred in serum-free media and 1% FBS. In confluent cultures, cells in all media conditions proliferated. TGF-β1 had an inhibitory effect in actively proliferating cultures. There was a positive correlation between the inhibitory effects of TGF-β1 and smooth-muscle cell growth rate (r = .65; P = 0.005). Conclusions: When confluent, human arterial smooth-muscle cells continue to proliferate after serum deprivation, suggesting that these cells are capable of conditioning their own medium. TGF-β1 inhibits smooth-muscle cell proliferation in a growth-rate-dependent manner. These data suggest that TGF-B1 may have a growth-regulatory role in vascular disease by counteracting states of arterial smooth-muscle cell proliferation.

UR - http://www.scopus.com/inward/record.url?scp=0028982828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028982828&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(99)80284-0

DO - 10.1016/S0002-9610(99)80284-0

M3 - Article

C2 - 7631929

AN - SCOPUS:0028982828

VL - 170

SP - 193

EP - 197

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 2

ER -